PT Lippo Karawaci Tbk (ISX:LPKR) Altman Z2-Score: 5.40 (As of Jul. 14, 2026) — Near Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ISX:LPKR PT Lippo Karawaci Tbk ISX:LPKR
68 GF Score
Price Rp60.00
GF Value Rp60.74
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is PT Lippo Karawaci Tbk Altman Z2-Score?

PT Lippo Karawaci Tbk ISX:LPKR 68 Altman Z2-Score is 5.40 as of Jul. 14, 2026, which is 5% above its 10-year median of 5.12. GuruFocus rates ISX:LPKR with a GF Score™ of 68/100 and a GF Value™ of Rp60.74 (Fairly Valued). The stock has 4 warning signs investors should review. Among 677 Healthcare Providers & Services companies, PT Lippo Karawaci Tbk ranks better than 78.58% on this metric.

Altman Z2-Score, also known as Z"-Score, is used to predict the likelihood that a non-manufacturing company (excluding property/financial company) will face bankruptcy within a two-year period.

Good Sign:

PT Lippo Karawaci Tbk has a Altman Z2-Score of 5.40, indicating it is in Safe Zones. This implies the Altman Z2-Score is strong.

The zones of discrimination were as such:

When Altman Z2-Score <= 1.1, it is in Distress Zones.
When Altman Z2-Score >= 2.6, it is in Safe Zones.
When Altman Z2-Score is between 1.1 and 2.6, it is in Grey Zones.

The historical rank and industry rank for PT Lippo Karawaci Tbk's Altman Z2-Score or its related term are showing as below:

ISX:LPKR' s Altman Z2-Score Range Over the Past 10 Years
Min: 1.77   Med: 5.12   Max: 7.78
Current: 5.4

During the past 13 years, PT Lippo Karawaci Tbk's highest Altman Z2-Score was 7.78. The lowest was 1.77. And the median was 5.12.


PT Lippo Karawaci Tbk  (ISX:LPKR) Altman Z2-Score Explanation

The original Z-Score model was based on publicly traded manufacturing companies while the Z2-Score, also known as Z"-score can be used for any type of company excluding property/financial companies. Both Z-Score and Z2-Score describes the financial health of a company, and its likelihood of financial distress.

X1: The Working Capital/Total Assets (WC/TA) ratio is a measure of the net liquid assets of the firm relative to the total capitalization. Working capital is defined as the difference between current assets and current liabilities. Ordinarily, a firm experiencing consistent operating losses will have shrinking current assets in relation to total assets. Altman found this one proved to be the most valuable liquidity ratio comparing with the current ratio and the quick ratio. This is however the least significant of the five factors.

X2: Retained Earnings/Total Assets: the RE/TA ratio measures the leverage of a firm. Retained earnings is the account which reports the total amount of reinvested earnings and/or losses of a firm over its entire life. Those firms with high RE, relative to TA, have financed their assets through retention of profits and have not utilized as much debt.

X3, Earnings Before Interest and Taxes/Total Assets (EBIT/TA): This ratio is a measure of the true productivity of the firm's assets, independent of any tax or leverage factors. Since a firm's ultimate existence is based on the earning power of its assets, this ratio appears to be particularly appropriate for studies dealing with corporate failure. This ratio continually outperforms other profitability measures, including cash flow.

X4_2, Net Worth (Total Stockholders Equity - Preferred Stock)/Total Liabilities (NW/TL): it compares a company’s stock net worth with its total liabilities and can be used to assess the extent of its reliance on debt.

Read more about Altman Z2-Score, the original research on Z-Score and the additional research on Z2-Score.


Be Aware

Altman Z2-Score does not apply to financial companies.


PT Lippo Karawaci Tbk Altman Z2-Score Related Terms


PT Lippo Karawaci Tbk Altman Z2-Score Historical Data

* Premium members only.

The historical data trend for PT Lippo Karawaci Tbk's Altman Z2-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PT Lippo Karawaci Tbk Altman Z2-Score Chart

PT Lippo Karawaci Tbk Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Altman Z2-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.05 2.40 2.87 7.28 5.45

PT Lippo Karawaci Tbk Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Altman Z2-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.78 5.09 5.56 5.45 5.40

ISX:LPKR vs HCA, THC, DVA: Altman Z2-Score Comparison

For the Medical Care Facilities subindustry, PT Lippo Karawaci Tbk's Altman Z2-Score, along with its competitors' market caps and Altman Z2-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PT Lippo Karawaci Tbk Altman Z2-Score vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, PT Lippo Karawaci Tbk's Altman Z2-Score distribution charts can be found below:

* The bar in red indicates where PT Lippo Karawaci Tbk's Altman Z2-Score falls into.


ISX:LPKR
68GF Score
PT Lippo Karawaci Tbk ISX:LPKR
Altman Z2-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PT Lippo Karawaci Tbk Altman Z2-Score Calculation

Altman Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.

Z2-Score, also known as Z"-Score is the Z-Score for non-manufacturing companies excluding property/financial companies.

PT Lippo Karawaci Tbk's Altman Z2-Score for today is calculated with this formula:

Z=6.56*X1+3.26*X2+6.72*X3+1.05*X4_2
=6.56*0.4436+3.26*0.1731+6.72*0.0277+1.05*1.656
=5.40

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency. GuruFocus does not calculate Altman Z2-Score when X4_2 value is 0.

Trailing Twelve Months (TTM) ended in Mar. 2026:
Total Assets was Rp48,702,211 Mil.
Total Current Assets was Rp29,063,892 Mil.
Total Current Liabilities was Rp7,458,053 Mil.
Retained Earnings was Rp8,429,591 Mil.
Pre-Tax Income was 137422 + 158414 + 261959 + -619 = Rp557,176 Mil.
Interest Expense was -197172 + -181024 + -225115 + -189632 = Rp-792,943 Mil.
Total Liabilities was Rp17,988,977 Mil.

* Note that for stock reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data.

X1=Working Capital/Total Assets
=(Total Current Assets - Total Current Liabilities)/Total Assets
=(29063892 - 7458053)/48702211
=0.4436

X2=Retained Earnings/Total Assets
=8429591/48702211
=0.1731

X3=Earnings Before Interest and Taxes/Total Assets
=(Pre-Tax Income - Interest Expense)/Total Assets
=(557176 - -792943)/48702211
=0.0277

X4_2=Net Worth/Total Liabilities
=(Total Stockholders Equity - Preferred Stock)/Total Liabilities
=(29789762 - 0)/17988977
=1.656

The zones of discrimination were as such:

Distress Zones - 1.1 < Grey Zones < 2.6 - Safe Zones

PT Lippo Karawaci Tbk has a Altman Z2-Score of 5.40 indicating it is in Safe Zones.

Frequently Asked Questions Learn more about Altman Z2-Score →
What does a Altman Z2-Score of 5.40 mean?
PT Lippo Karawaci Tbk (ISX:LPKR) has a Altman Z2-Score of 5.40 as of Jul. 14, 2026. Z2-Score is the Z-Score for non-manufacturing companies excluding property/financial companies, which measures a company's bankruptcy risk. View historical data on PT Lippo Karawaci Tbk and its competitors. This is near median its historical median of 5.12. Over the past decade, PT Lippo Karawaci Tbk's Altman Z2-Score has ranged from 1.77 to 7.78. According to the industry distribution chart, PT Lippo Karawaci Tbk ranks #145 out of 677 companies in the Healthcare Providers & Services industry, placing it in the top 21.4%.
Is PT Lippo Karawaci Tbk's Altman Z2-Score too high?
PT Lippo Karawaci Tbk's current Altman Z2-Score of 5.40 is near median its 10-year median of 5.12. Over the past 10 years, this metric has ranged from a low of 1.77 to a high of 7.78. The Healthcare Providers & Services industry median Altman Z2-Score is 2.18. PT Lippo Karawaci Tbk's value of 5.40 is 147.7% above this industry median. Based on the distribution chart, PT Lippo Karawaci Tbk ranks #145 out of 677 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, PT Lippo Karawaci Tbk has a GF Score™ of 68/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does PT Lippo Karawaci Tbk's Altman Z2-Score compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, PT Lippo Karawaci Tbk ranks #145 out of 677 companies for Altman Z2-Score. This places PT Lippo Karawaci Tbk in the top 21% of its industry — outperforming the majority of peers. The industry median Altman Z2-Score is 2.18. PT Lippo Karawaci Tbk's value of 5.40 is 147.7% above this benchmark. Historically, PT Lippo Karawaci Tbk's own Altman Z2-Score has ranged from 1.77 to 7.78 over the past decade. While the company's 10-year median is 5.12 vs. the industry median of 2.18, PT Lippo Karawaci Tbk has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Altman Z2-Score for a Healthcare Providers & Services company?
The median Altman Z2-Score among Healthcare Providers & Services companies is 2.18, based on 677 companies in the industry. Companies in the top quartile (top 25%) have a Altman Z2-Score significantly above this median, while those in the bottom quartile fall well below. However, Altman Z2-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PT Lippo Karawaci Tbk's current Altman Z2-Score of 5.40 is 147.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Altman Z2-Score mean?
A high Altman Z2-Score can signal that a stock is expensive relative to its fundamentals. Z2-Score is the Z-Score for non-manufacturing companies excluding property/financial companies, which measures a company's bankruptcy risk. View historical data on PT Lippo Karawaci Tbk and its competitors. For the Healthcare Providers & Services industry, the median Altman Z2-Score is 2.18 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Lippo Karawaci Tbk's current Altman Z2-Score is 5.40, which is near median its own 10-year median of 5.12. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Lippo Karawaci Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Lippo Karawaci Tbk (ISX:LPKR) is currently considered Fairly Valued. The stock's GF Value™ is Rp60.74, compared to a current price of Rp60.00 — trading 1.2% below its estimated fair value. The current Altman Z2-Score is 5.40, which is near median its 10-year median of 5.12 and 147.7% above the Healthcare Providers & Services industry median of 2.18. PT Lippo Karawaci Tbk's overall GF Score™ is 68/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Altman Z2-Score calculated?
Altman Z2-Score is calculated from a company's financial statements. For PT Lippo Karawaci Tbk (ISX:LPKR), the current Altman Z2-Score is 5.40 as of Jul. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PT Lippo Karawaci Tbk (ISX:LPKR) Overvalued in 2026?

Based on GuruFocus' analysis, PT Lippo Karawaci Tbk stock appears to be undervalued. The current stock price of Rp60.00 is trading 1.2% below its estimated GF Value™ of Rp60.74. GuruFocus considers PT Lippo Karawaci Tbk to be Fairly Valued.

Key valuation signals for ISX:LPKR:

  • Altman Z2-Score: 5.40 (near median its 10-year median of 5.12)
  • GF Value™: Rp60.74 vs. price of Rp60.00 (1.2% below fair value)
  • GF Score™: 68/100 with 4 warning signs
  • Industry Position: 147.7% above the Healthcare Providers & Services median (#145 of 677)

No single metric tells the full story. See the ISX:LPKR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


PT Lippo Karawaci Tbk Business Description

Address Jl. Boulevard Palem Raya No.7, Menara Matahari, 22nd floor, Lippo Karawaci Central, Tangerang District, Banten, Tangerang, IDN, 15811
PT Lippo Karawaci Tbk is engaged in property development activities including area development, residential property development and sales, commercial property, light industrial property, and integrated property projects. As part of its large scale integrated development portfolio, the Company develops projects within strategic locations comprising residential, office, mall, hotel, entertainment, education, and healthcare facilities. Its portfolio includes residential and urban development, hospitals, malls, and hotels and leisure assets. The Company has developed and manages urban property areas mainly in Java and Sulawesi, and operates across real estate, lifestyle, and healthcare segments, providing services across Indonesia.
68GF Score

Get the complete analysis for ISX:LPKR

Altman Z2-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

Rp60.00
Price
Rp60.74
GF Value